Peter's Premarket Perspective Monday, December 23, 2024

Slated for a flattish open on o/n inventory that is net long All overnight distribution in the upper part of Friday's large range Eli Lilly (LLY): FDA approves Zepbound (tirzepatide)...

This content is available only to members. To access this post, you must purchase Peter's Premarket Perspective, ShadowTrader Weekly Options Advisory, ShadowTrader Weekly Options Advisory 12 Months | 20% discount, ShadowTrader Weekly Options Advisory 3 Months | 10% discount, Peter's Premarket Perspective 7 Day Free Trial (5 Issues), ShadowTrader Live Trading Suite 3 Months | 10% discount, ShadowTrader Live Trading Suite 12 Months | 20% discount, ShadowTrader Live Trading Suite, Live Trading Suite 7 Dollar Trial or ShadowTrader Weekly Options Advisory $7 Trial.

If you already have an account with access to these products, please login below to access this post.

Log In

Next PostPeter's Premarket Perspective Friday, December 20, 2024

Disclaimer for www.shadowtrader.net

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Shadow Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade.

The information provided on www.shadowtrader.net is for general informational purposes only. While we strive to ensure the accuracy and reliability of the information presented, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

Trading and investing in financial markets involve risks, and past performance is not indicative of future results. The content provided on www.shadowtrader.net is not intended to be financial or investment advice. You should seek professional advice or conduct your own research before making any investment decisions.

Any reliance you place on the information provided on www.shadowtrader.net is strictly at your own risk. We shall not be liable for any loss or damage, including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through www.shadowtrader.net, you may be able to link to other websites that are not under our control. We have no control over the nature, content, and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorsement of the views expressed within them.

Every effort is made to keep www.shadowtrader.net up and running smoothly. However, we take no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

By using www.shadowtrader.net, you acknowledge and agree to the terms of this disclaimer. If you do not agree with any part of this disclaimer, please do not use our website.

This disclaimer is subject to change without notice.

Last Updated: Friday, November 22, 2024

Peter’s Premarket Perspective Monday, December 23, 2024

Next PostPeter's Premarket Perspective Friday, December 20, 2024

Contact Us

About

Legal

SHADOWTRADER APP